Rei Tsang Shiao

Array ( [id] => 7586380 [patent_doc_number] => 20110280890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'PRODRUGS OF CC-1065 ANALOGS' [patent_app_type] => utility [patent_app_number] => 13/184255 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16779 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280890.pdf [firstpage_image] =>[orig_patent_app_number] => 13184255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9140322 [patent_doc_number] => 08580784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Method for treating a disease related to the glucocorticoid receptor' [patent_app_type] => utility [patent_app_number] => 13/135765 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24691 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13135765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8928513 [patent_doc_number] => 20130184273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'BICYCLIC PYRIMIDINES' [patent_app_type] => utility [patent_app_number] => 13/808461 [patent_app_country] => US [patent_app_date] => 2011-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36576 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153709 [patent_doc_number] => 08586615 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Modulators of cystic fibrosis transmembrane conductance regulator' [patent_app_type] => utility [patent_app_number] => 13/178677 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34502 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13178677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502279 [patent_doc_number] => 20110263874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Process for Producing Cyclic Compounds' [patent_app_type] => utility [patent_app_number] => 13/175601 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6500 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263874.pdf [firstpage_image] =>[orig_patent_app_number] => 13175601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099673 [patent_doc_number] => 08563551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Method for preventing or treating a disease related to the glucocorticoid receptor' [patent_app_type] => utility [patent_app_number] => 13/135256 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27084 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13135256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8469869 [patent_doc_number] => 08299047 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => '2-alkyl-cycloalk(en)yl-carboxamides' [patent_app_type] => utility [patent_app_number] => 13/173723 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20534 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13173723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501711 [patent_doc_number] => 20110263589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Method for preventing or treating a glucocorticoid receptor-related disease' [patent_app_type] => utility [patent_app_number] => 13/135164 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 94077 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263589.pdf [firstpage_image] =>[orig_patent_app_number] => 13135164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8780643 [patent_doc_number] => 20130102618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => '3-AMINO-5,6-DIHYDRO-1H-PYRAZIN-2-ONE DERIVATIVES USEFUL FOR THE TREATMENT OF ALZHEIMER\'S DISEASE AND OTHER FORMS OF DEMENTIA' [patent_app_type] => utility [patent_app_number] => 13/806214 [patent_app_country] => US [patent_app_date] => 2011-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16850 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8780646 [patent_doc_number] => 20130102621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'NOVEL CONDENSED PYRIDINE OR CONDENSED PYRIMIDINE DERIVATIVE, AND MEDICINAL AGENT COMPRISING SAME' [patent_app_type] => utility [patent_app_number] => 13/806940 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23053 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9166750 [patent_doc_number] => 08592427 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives' [patent_app_type] => utility [patent_app_number] => 13/168497 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18813 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13168497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8921073 [patent_doc_number] => 08487008 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/166688 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8786 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13166688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663677 [patent_doc_number] => 20110312946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF DIABETES' [patent_app_type] => utility [patent_app_number] => 13/165549 [patent_app_country] => US [patent_app_date] => 2011-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13112 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312946.pdf [firstpage_image] =>[orig_patent_app_number] => 13165549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9703942 [patent_doc_number] => 08829003 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Compounds for treating proliferative disorders' [patent_app_type] => utility [patent_app_number] => 13/806602 [patent_app_country] => US [patent_app_date] => 2011-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 22883 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664472 [patent_doc_number] => 08377933 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Method for treating a pulmonary hypertension condition' [patent_app_type] => utility [patent_app_number] => 13/162137 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20285 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13162137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8866907 [patent_doc_number] => 20130150610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'PROCESS FOR MAKING NITRILES' [patent_app_type] => utility [patent_app_number] => 13/808795 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 43139 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9552282 [patent_doc_number] => 08759331 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'X-ray and gamma-photon activable organic compounds, their preparation and their uses' [patent_app_type] => utility [patent_app_number] => 13/704495 [patent_app_country] => US [patent_app_date] => 2011-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7141 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669568 [patent_doc_number] => 20110318837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS BY STIMULATING ER STRESS' [patent_app_type] => utility [patent_app_number] => 13/160291 [patent_app_country] => US [patent_app_date] => 2011-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18250 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13160291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580944 [patent_doc_number] => 20110294827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'IAP BINDING COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/152644 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41384 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294827.pdf [firstpage_image] =>[orig_patent_app_number] => 13152644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9762347 [patent_doc_number] => 08846671 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/807678 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 14991 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807678 [rel_patent_id] =>[rel_patent_doc_number] =>)